- Home
- Our People
- Associate Professor Natasa Gisev
Associate Professor Natasa Gisev
Tabs
Publications related to this Person
Book Chapters
Gisev N; Sluggett J, 2019, 'Descriptive and Drug Utilization Studies', in Babar Z-U-D (ed.), Encyclopedia of Pharmacy Practice and Clinical Pharmacy, ACADEMIC PR INC
Nielsen S; Gisev N, 2017, 'Drug Pharmacology and Pharmacotherapy Treatments', in Ritter A; King T; Lee N (ed.), Drug Use and Australian Society 2nd Edition, edn. 2nd, OUP
Gisev N, 2010, 'Case 24: Neurologic and Psychotropic', in Chen T; Moles R; Basger B; Nishtala P (ed.), Case Studies in Practice: Medication Review: A Process Guide for Pharmacists
Gisev N, 2010, 'Case 25: Psychotropic, Cardiovascular, Endocrine, Respiratory, Gastrointestinal and Neurological', in Chen T; Moles R; Basger B; Nishtala P (ed.), Case Studies in Practice: Medication Review: A Process Guide for Pharmacists
Journal articles
Bharat C; Degenhardt L; Pearson S-A; Buizen L; Wilson A; Dobbins T; Gisev N, 2022, 'A data-informed approach using individualised dispensing patterns (IDP) to estimate medicine exposure periods and dose from pharmaceutical claims data.', Pharmacoepidemiol Drug Saf, http://dx.doi.org/10.1002/pds.5567
Erthal-Williamson J; Clare P; Gisev N; Santoso C; Berterame S, 2022, 'Trends in pharmaceutical opioid consumption in the World Health Organization Eastern Mediterranean Region, 2010–2019', Eastern Mediterranean Health Journal, http://dx.doi.org/10.26719/emhj.22.085
Bharat C; Gisev N; Barbieri S; Dobbins T; Larney S; Farrell M; Degenhardt L, 2022, 'Trends in opioid analgesic utilisation among people with a history of opioid dependence', Drug and Alcohol Dependence, vol. 238, pp. 109548 - 109548, http://dx.doi.org/10.1016/j.drugalcdep.2022.109548
Bharat C; Gisev N; Barbieri S; Dobbins T; Larney S; Farrell M; Degenhardt L, 2022, 'The effect of opioid analgesics, benzodiazepines, gabapentinoids, and opioid agonist treatment on mortality risk among opioid-dependent people.', International Journal of Population Data Science, vol. 7, http://dx.doi.org/10.23889/ijpds.v7i3.1954
Hopkins RE; Campbell G; Degenhardt L; Lintzeris N; Larance B; Nielsen S; Gisev N, 2022, 'Self-reported challenges obtaining ongoing prescription opioids among Australians with chronic non-cancer pain', International Journal of Drug Policy, vol. 105, pp. 103708, http://dx.doi.org/10.1016/j.drugpo.2022.103708
Hopkins RE; Campbell G; Degenhardt L; Nielsen S; Blyth F; Cohen M; Gisev N, 2022, 'Use of pharmacological and nonpharmacological treatments for chronic noncancer pain among people using opioids: a longitudinal cohort study', Pain, vol. 163, pp. 1049 - 1059, http://dx.doi.org/10.1097/j.pain.0000000000002484
Rahman S; Trussell A; Pearson SA; Buckley NA; Karanges EA; Cairns R; Litchfield M; Todd A; Gisev N, 2022, 'Trends in transdermal fentanyl utilisation and fatal fentanyl overdose across Australia (2003–2015)', Drug and Alcohol Review, vol. 41, pp. 435 - 443, http://dx.doi.org/10.1111/dar.13391
Santo T; Campbell G; Gisev N; Degenhardt L, 2022, 'Exposure to childhood trauma increases risk of opioid use disorder among people prescribed opioids for chronic non-cancer pain', Drug and Alcohol Dependence, vol. 230, http://dx.doi.org/10.1016/j.drugalcdep.2021.109199
Yuen WS; Leung J; Man N; Chiu V; Gisev N; Livingston M; Degenhardt L; Farrell M; Pearson SA; Dobbins T; Dunlop A; Mattick RP; Peacock A, 2022, 'Age at first alcohol-related hospital separation or emergency department presentation and rate of re-admission: A retrospective data linkage cohort of young Australians', Drug and Alcohol Review, http://dx.doi.org/10.1111/dar.13529
Bharat C; Larney S; Barbieri S; Dobbins T; Jones NR; Hickman M; Gisev N; Ali R; Degenhardt L, 2021, 'The effect of person, treatment and prescriber characteristics on retention in opioid agonist treatment: a 15-year retrospective cohort study', Addiction, vol. 116, pp. 3139 - 3152, http://dx.doi.org/10.1111/add.15514
de Oliveira Costa J; Bruno C; Baranwal N; Gisev N; Dobbins TA; Degenhardt L; Pearson SA, 2021, 'Variations in Long-term Opioid Therapy Definitions: A Systematic Review of Observational Studies Using Routinely Collected Data (2000-2019)', British Journal of Clinical Pharmacology, vol. 87, pp. 3706 - 3720, http://dx.doi.org/10.1111/bcp.14798
Ilomaki J; Lalic S; Gisev N; Nielsen S, 2021, '1045Patterns, predictors and outcomes of opioid use in Australia: evidence for an epidemic?', International Journal of Epidemiology, vol. 50, http://dx.doi.org/10.1093/ije/dyab168.309
Nielsen S; Gisev N; Leung J; Clare P; Bruno R; Lintzeris N; Larance B; Blyth F; Hall W; Cohen M; Degenhardt L; Farrell M; Campbell G, 2021, 'Clinical correlates and outcomes associated with pregabalin use among people prescribed opioids for chronic non-cancer pain: A five-year prospective cohort study', British Journal of Clinical Pharmacology, vol. 87, pp. 3092 - 3104, http://dx.doi.org/10.1111/bcp.14715
Sutherland R; Jayathilake R; Peacock A; Dietze P; Bruno R; Reddel S; Gisev N, 2021, 'Trends and characteristics of extra-medical use of quetiapine among people who regularly inject drugs in Australia, 2011–2018', Drug and Alcohol Dependence, vol. 221, http://dx.doi.org/10.1016/j.drugalcdep.2021.108636
Santo T; Campbell G; Gisev N; Tran LT; Colledge S; Di Tanna GL; Degenhardt L, 2021, 'Prevalence of childhood maltreatment among people with opioid use disorder: A systematic review and meta-analysis', Drug and Alcohol Dependence, vol. 219, pp. 108459 - 108459, http://dx.doi.org/10.1016/j.drugalcdep.2020.108459
Gisev N; Brett J; Peacock A, 2020, 'Extra-medical use of antipsychotics: what can be learnt from experiences with other prescription medicines?', Addiction, vol. 115, pp. 1203 - 1205, http://dx.doi.org/10.1111/add.14823
Sutherland R; Dietze PM; Gisev N; Bruno R; Campbell G; Memedovic S; Peacock A, 2020, 'Patterns and correlates of prescribed and non-prescribed pregabalin use among a sample of people who inject drugs in Australia', Drug and Alcohol Review, vol. 39, pp. 568 - 574, http://dx.doi.org/10.1111/dar.13083
Lalic S; Gisev N; Bell JS; Ilomäki J, 2020, 'Transition to high-dose or strong opioids: a population-based study of people initiating opioids in Australia', Addiction, vol. 115, pp. 1088 - 1097, http://dx.doi.org/10.1111/add.14926
Schaffer AL; Cairns R; Brown JA; Gisev N; Buckley NA; Pearson SA, 2020, 'Changes in sales of analgesics to pharmacies after codeine was rescheduled as a prescription only medicine', Medical Journal of Australia, vol. 212, pp. 321 - 327, http://dx.doi.org/10.5694/mja2.50552
Santo T; Larance B; Bruno R; Gisev N; Nielsen S; Degenhardt L; Campbell G, 2020, 'Correlates of indicators of potential extra-medical opioid use in people prescribed opioids for chronic non-cancer pain', Drug and Alcohol Review, vol. 39, pp. 128 - 134, http://dx.doi.org/10.1111/dar.13021
Peacock A; Gisev N; Memedovic S; Larance B; Brown J; Cairns R; Buckley N; Farrell M; Degenhardt L, 2020, 'Opioid use and harms associated with a sustained-release tapentadol formulation: A post-marketing surveillance study.', Drug Alcohol Depend, vol. 206, pp. 107697, http://dx.doi.org/10.1016/j.drugalcdep.2019.107697
Gisev N; Nielsen S; Campbell G; Santo T; Mant A; Bruno R; Cohen M; Hall WD; Larance B; Lintzeris N; Farrell M; Degenhardt L, 2019, 'Antidepressant Use among People Prescribed Opioids for Chronic Noncancer Pain', Pain Medicine (United States), vol. 20, pp. 2450 - 2458, http://dx.doi.org/10.1093/pm/pnz009
Roxburgh A; Hall WD; Gisev N; Degenhardt L, 2019, 'Characteristics and circumstances of heroin and pharmaceutical opioid overdose deaths: Comparison across opioids', Drug and Alcohol Dependence, vol. 205, http://dx.doi.org/10.1016/j.drugalcdep.2019.06.035
Peacock A; Bruno R; Gisev N; Degenhardt L; Hall W; Sedefov R; White J; Thomas KV; Farrell M; Griffiths P, 2019, 'New psychoactive substances: challenges for drug surveillance, control, and public health responses', The Lancet, vol. 394, pp. 1668 - 1684, http://dx.doi.org/10.1016/S0140-6736(19)32231-7
Jones NR; Shanahan M; Dobbins T; Degenhardt L; Montebello M; Gisev N; Larney S, 2019, 'Reductions in emergency department presentations associated with opioid agonist treatment vary by geographic location: A retrospective study in New South Wales, Australia', Drug and Alcohol Review, vol. 38, pp. 690 - 698, http://dx.doi.org/10.1111/dar.12976
Peacock A; Chiu V; Leung J; Dobbins T; Larney S; Gisev N; Pearson SA; Degenhardt L, 2019, 'Protocol for the Data-Linkage Alcohol Cohort Study (DACS): Investigating mortality, morbidity and offending among people with an alcohol-related problem using linked administrative data', BMJ Open, vol. 9, pp. e030605, http://dx.doi.org/10.1136/bmjopen-2019-030605
Gisev N; Bharat C; Larney S; Dobbins T; Weatherburn D; Hickman M; Farrell M; Degenhardt L, 2019, 'The effect of entry and retention in opioid agonist treatment on contact with the criminal justice system among opioid-dependent people: a retrospective cohort study', The Lancet Public Health, vol. 4, pp. e334 - e342, http://dx.doi.org/10.1016/S2468-2667(19)30060-X
Lalic S; Bell JS; Gyllensten H; Gisev N; Friberg E; Ilomaki J; Sluggett JK; Mittendorfer-Rutz E; Alexanderson K, 2019, 'Trajectories of sickness absence and disability pension before and after opioid initiation for noncancer pain: A 10-year population-based study', Pain, vol. 160, pp. 1224 - 1233, http://dx.doi.org/10.1097/j.pain.0000000000001500
Gisev N; Pearson SA; Larance B; Larney S; Blanch B; Degenhardt L, 2019, 'A population-based study of transdermal fentanyl initiation in Australian clinical practice', European Journal of Clinical Pharmacology, vol. 75, pp. 401 - 408, http://dx.doi.org/10.1007/s00228-018-2588-0
Lalic S; Ilomäki J; Bell JS; Korhonen MJ; Gisev N, 2019, 'Prevalence and incidence of prescription opioid analgesic use in Australia', British Journal of Clinical Pharmacology, vol. 85, pp. 202 - 215, http://dx.doi.org/10.1111/bcp.13792
Campbell G; Lintzeris N; Gisev N; Larance B; Pearson S; Degenhardt L, 2019, 'Regulatory and other responses to the pharmaceutical opioid problem', Medical Journal of Australia, vol. 210, pp. 6 - 8, http://dx.doi.org/10.5694/mja2.12047
Gisev N; Pearson SA; Dobbins T; Currow DC; Blyth F; Larney S; Dunlop A; Mattick RP; Wilson A; Degenhardt L, 2018, 'Combating escalating harms associated with pharmaceutical opioid use in Australia: The POPPY II study protocol', BMJ Open, vol. 8, pp. e025840, http://dx.doi.org/10.1136/bmjopen-2018-025840
Gisev N; Campbell G; Lalic S; Larney S; Peacock A; Nielsen S; Pearson SA; Degenhardt L, 2018, 'Current Opioid Access, Use, and Problems in Australasian Jurisdictions', Current Addiction Reports, vol. 5, pp. 464 - 472, http://dx.doi.org/10.1007/s40429-018-0227-6
Blanch B; Degenhardt L; Buckley NA; Gisev N; Dobbins T; Karanges EA; Larance B; Larney S; Pearson SA, 2018, 'Prescription opioid access patterns and factors associated with increasing number of prescribers, pharmacies, and dispensings: An observational study using pharmaceutical claims', Pain Medicine (United States), vol. 19, pp. 1170 - 1183, http://dx.doi.org/10.1093/pm/pnx035
Gisev N; Pearson SA; Karanges EA; Larance B; Buckley NA; Larney S; Dobbins T; Blanch B; Degenhardt L, 2018, 'To what extent do data from pharmaceutical claims under-estimate opioid analgesic utilisation in Australia?', Pharmacoepidemiology and Drug Safety, vol. 27, pp. 550 - 555, http://dx.doi.org/10.1002/pds.4329
Larance B; Gisev N; Cama E; Nelson EC; Darke S; Larney S; Degenhardt L, 2018, 'Predictors of transitions across stages of heroin use and dependence prior to treatment-seeking among people in treatment for opioid dependence', Drug and Alcohol Dependence, vol. 191, pp. 145 - 151, http://dx.doi.org/10.1016/j.drugalcdep.2018.03.056
Gisev N; Larance B; Cama E; Nielsen S; Roxburgh A; Bruno R; Degenhardt L, 2018, 'A nationwide study of the extent and factors associated with fentanyl use in Australia', Research in Social and Administrative Pharmacy, vol. 14, pp. 303 - 308, http://dx.doi.org/10.1016/j.sapharm.2017.04.002
Lalic S; Gisev N; Bell JS; Korhonen M; Ilomaki J, 2018, 'Predictors of persistent prescription opioid analgesic use among people without cancer in Australia', British Journal of Clinical Pharmacology, vol. 84, pp. 1267 - 1278, http://dx.doi.org/10.1111/bcp.13556
Lalic S; Jokanovic N; Ilomäki J; Gisev N; Lloyd B; Lubman DI; Bell JS, 2018, 'Harms associated with extramedical use of prescription opioid analgesics in Australia: A scoping review', Research in Social and Administrative Pharmacy, http://dx.doi.org/10.1016/j.sapharm.2018.07.001
Larance B; Degenhardt L; Peacock A; Gisev N; Mattick R; Colledge S; Campbell G, 2017, 'Pharmaceutical opioid use and harm in Australia: The need for proactive and preventative responses', Drug and Alcohol Review, vol. 37, pp. S203 - S205, http://dx.doi.org/10.1111/dar.12617
Roxburgh A; Hall WD; Dobbins T; Gisev N; Burns L; Pearson S; Degenhardt L, 2017, 'Trends in heroin and pharmaceutical opioid overdose deaths in Australia', Drug and Alcohol Dependence, vol. 179, pp. 291 - 298, http://dx.doi.org/10.1016/j.drugalcdep.2017.07.018
Nielsen S; Gisev N; Bruno R; Hall W; Cohen M; Larance B; Campbell G; Shanahan M; Blyth F; Lintzeris N; Pearson S; Mattick R; Degenhardt L, 2017, 'Defined daily doses (DDD) do not accurately reflect opioid doses used in contemporary chronic pain treatment', Pharmacoepidemiology and Drug Safety, vol. 26, pp. 587 - 591, http://dx.doi.org/10.1002/pds.4168
Nielsen S; Degenhardt L; Hoban B; Gisev N, 2016, 'A synthesis of oral morphine equivalents (OME) for opioid utilisation studies', Pharmacoepidemiology and Drug Safety, vol. 25, pp. 733 - 737, http://dx.doi.org/10.1002/pds.3945
Degenhardt L; Gisev N; Cama E; Nielsen S; Larance B; Bruno R, 2016, 'The extent and correlates of community-based pharmaceutical opioid utilisation in Australia', Pharmacoepidemiology and Drug Safety, vol. 25, pp. 521 - 538, http://dx.doi.org/10.1002/pds.3931
Gisev N; Nielsen S; Cama E; Larance B; Bruno R; Degenhardt L, 2016, 'An ecological study of the extent and factors associated with the use of prescription and over-the-counter codeine in Australia', European Journal of Clinical Pharmacology, vol. 72, pp. 469 - 494, http://dx.doi.org/10.1007/s00228-015-1995-8
Gisev N; Pearson SA; Blanch B; Larance B; Dobbins T; Larney S; Degenhardt L, 2016, 'Initiation of strong prescription opioids in Australia: cohort characteristics and factors associated with the type of opioid initiated', British Journal of Clinical Pharmacology, vol. 82, pp. 1123 - 1133, http://dx.doi.org/10.1111/bcp.13026
Gisev N; Shanahan M; Weatherburn DJ; Mattick RP; Larney S; Burns L; Degenhardt L, 2015, 'A cost-effectiveness analysis of opioid substitution therapy upon prison release in reducing mortality among people with a history of opioid dependence', Addiction, vol. 110, pp. 1975 - 1984, http://dx.doi.org/10.1111/add.13073
Hoban B; Larance B; Gisev N; Nielsen S; Cohen M; Bruno R; Shand F; Lintzeris N; Hall W; Farrell M; Degenhardt L, 2015, 'The use of paracetamol (acetaminophen) among a community sample of people with chronic non-cancer pain prescribed opioids', International Journal of Clinical Practice, vol. 69, pp. 1366 - 1376, http://dx.doi.org/10.1111/ijcp.12716
Gisev N; Larney S; Kimber J; Burns L; Weatherburn D; Gibson A; Dobbins T; Mattick RP; Butler T; Degenhardt L, 2015, 'Determining the impact of opioid substitution therapy upon mortality and recidivism among prisoners: A 22 year data linkage study', Trends and Issues in Crime and Criminal Justice
Burns L; Gisev N; Larney S; Dobbins T; Gibson A; Kimber J; Larance B; Mattick RP; Butler T; Degenhardt L, 2015, 'A longitudinal comparison of retention in buprenorphine and methadone treatment for opioid dependence in New South Wales, Australia', Addiction, vol. 110, pp. 646 - 655, http://dx.doi.org/10.1111/add.12834
Degenhardt L; Blanch B; Gisev N; Larance B; Pearson S, 2015, 'The POPPY Research Programme protocol: Investigating opioid utilisation, costs and patterns of extramedical use in Australia', BMJ Open, vol. 5, http://dx.doi.org/10.1136/bmjopen-2014-007030
Nielsen S; Degenhardt L; Hoban B; Gisev N, 2015, 'A synthesis of oral morphine equivalents (OME) for opioid utilisation studies', Pharmacoepidemiology and Drug Safety, vol. 25, pp. 733 - 737, http://dx.doi.org/10.1002/pds.3945
Degenhardt L; Larney S; Kimber J; Gisev N; Farrell M; Dobbins T; Weatherburn DJ; Gibson A; Mattick R; Butler T; Burns L, 2015, 'The impact of opioid substitution therapy on mortality post-release from prison', Drug and Alcohol Dependence, vol. 146, pp. e260 - e260, http://dx.doi.org/10.1016/j.drugalcdep.2014.09.173
Larney S; Gisev N; Farrell M; Dobbins T; Burns L; Gibson A; Kimber J; Degenhardt L, 2015, 'Opioid substitution therapy as a strategy to reduce deaths in prison: Retrospective cohort study', Drug and Alcohol Dependence, vol. 146, pp. e168 - e168, http://dx.doi.org/10.1016/j.drugalcdep.2014.09.373
Gisev N; Gibson A; Larney S; Kimber J; Williams M; Clifford A; Doyle M; Burns L; Butler T; Weatherburn DJ; Degenhardt L, 2014, 'Offending, custody and opioid substitution therapy treatment utilisation among opioid-dependent people in contact with the criminal justice system: Comparison of Indigenous and non-Indigenous Australians', BMC Public Health, vol. 14, http://dx.doi.org/10.1186/1471-2458-14-920
Gisev N; Bell JS; Chen TF, 2014, 'A retrospective study of psychotropic drug use among individuals with mental illness issued a community treatment order', International Journal of Clinical Practice, vol. 68, pp. 236 - 244, http://dx.doi.org/10.1111/ijcp.12276
Degenhardt L; Larney S; Gisev N; Trevena J; Burns L; Kimber J; Shanahan M; Butler T; Mattick RP; Weatherburn D, 2014, 'Imprisonment of opioid-dependent people in New South Wales, Australia, 2000-2012: A retrospective linkage study', Australian and New Zealand Journal of Public Health, vol. 38, pp. 165 - 170, http://dx.doi.org/10.1111/1753-6405.12123
Degenhardt L; Larney S; Kimber J; Gisev N; Farrell M; Dobbins T; Weatherburn DJ; Gibson A; Mattick R; Butler T; Burns L, 2014, 'The impact of opioid substitution therapy on mortality post-release from prison: Retrospective data linkage study', Addiction, vol. 109, pp. 1306 - 1317, http://dx.doi.org/10.1111/add.12536
Larney S; Gisev N; Farrell M; Dobbins T; Burns L; Gibson A; Kimber J; Degenhardt L, 2014, 'Opioid substitution therapy as a strategy to reduce deaths in prison: Retrospective cohort study', BMJ Open, vol. 4, http://dx.doi.org/10.1136/bmjopen-2013-004666
Gisev N; Bell JS; Chen TF, 2014, 'Factors associated with antipsychotic polypharmacy and high-dose antipsychotics among individuals receiving compulsory treatment in the community', Journal of Clinical Psychopharmacology, vol. 34, pp. 307 - 312, http://dx.doi.org/10.1097/JCP.0000000000000098
Gisev N; Degenhardt L; Larney S; Larance B; Gibson A; Kimber J; Burns L, 2014, 'A comparative study of opioid substitution therapy utilisation among opioid-dependent men and women', Drug and Alcohol Review, vol. 33, pp. 499 - 505, http://dx.doi.org/10.1111/dar.12151
Gisev N; Bell S; Chen T, 2013, 'Psychotropic drug-regimen changes between community treatment orders', Australasian Psychiatry, vol. 21, pp. 411 - 412, http://dx.doi.org/10.1177/1039856213491845
Gisev N; Bell JS; Chen TF, 2013, 'Interrater agreement and interrater reliability: Key concepts, approaches, and applications', Research in Social and Administrative Pharmacy, vol. 9, pp. 330 - 338, http://dx.doi.org/10.1016/j.sapharm.2012.04.004
Degenhardt LJ; Gisev N; Trevena J; Larney S; Kimber J; Burns LA; Shanahan M; Weatherburn D, 2013, 'Engagement with the criminal justice system among opioid dependent people: Retrospective cohort study', Addiction, vol. 108, pp. 2152 - 2165, http://dx.doi.org/10.1111/add.12324
Gisev N; Hartikainen S; Chen TF; Korhonen M; Bell JS, 2012, 'Effect of comorbidity on the risk of death associated with antipsychotic use among community-dwelling older adults', International Psychogeriatrics, vol. 24, pp. 1058 - 1064, http://dx.doi.org/10.1017/S1041610212000117
Gisev N; Hartikainen S; Chen TF; Korhonen M; Bell JS, 2011, 'Mortality associated with benzodiazepines and benzodiazepine-related drugs among community-dwelling older people in Finland: A population-based retrospective cohort study', Canadian Journal of Psychiatry, vol. 56, pp. 377 - 381, http://dx.doi.org/10.1177/070674371105600609
Gisev N; Bell JS; O'Reilly CL; Rosen A; Chen TF, 2010, 'An expert panel assessment of comprehensive medication reviews for clients of community mental health teams', Social Psychiatry and Psychiatric Epidemiology, vol. 45, pp. 1071 - 1079, http://dx.doi.org/10.1007/s00127-009-0148-8
Chen TF; Gisev N; O'Reilly C; Nishtala P; Bell JS, 2009, 'Mind games: Pharmacists and mental health', Australian Journal of Pharmacy, vol. 90, pp. 70 - 72
Gisev N; Bell JS; McLachlan AJ; Chetty M; Chen TF, 2006, 'Psychiatric drug use among patients of a community mental health service: Patterns and implications', Disease Management and Health Outcomes, vol. 14, pp. 369 - 376, http://dx.doi.org/10.2165/00115677-200614060-00006
Conference Papers
Santo T; Campbell G; Gisev N; Martino-Burke D; Wilson J; Colledge-Frisby S; Clark B; Tran LT; Degenhardt L, 2022, 'Prevalence of mental disorders among people with opioid use disorder: A systematic review and meta-analysis', in Drug and Alcohol Dependence, http://dx.doi.org/10.1016/j.drugalcdep.2022.109551
Gisev N; Pearson S-A; Dobbins T; Buizen L; Murphy T; Wilson A; Blyth F; Dunlop A; Larney S; Currow D; Mattick R; Degenhardt L, 2021, 'POPPY II cohort profile- a population-based linked cohort examining the course and outcomes of prescription opioid use in NSW, Australia, 2003-2018', in PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, WILEY, pp. 300 - 301, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000687807300611&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
Gisev N, 2017, 'The safety of transdermal fentanyl initiation in Australian clinical practice', in The safety of transdermal fentanyl initiation in Australian clinical practice, 2017 Australasian Pharmaceutical Scientific Association - Australasian Society of Clinical and Experimental Pharmacologist and Toxicologists Joint Scientific Meeting, Brisbane, Australia, presented at 2017 Australasian Pharmaceutical Scientific Association - Australasian Society of Clinical and Experimental Pharmacologist and Toxicologists Joint Scientific Meeting, Brisbane, Australia, 05 December 2017 - 08 December 2017
Gisev N, 2017, 'Quantifying the extent that data from PBS/RPBS claims under-estimate opioid analgesic utilisation in Australia', in Quantifying the extent that data from PBS/RPBS claims under-estimate opioid analgesic utilisation in Australia, 10th Asian Conference on Pharmacoepidemiology, Brisbane, Australia, presented at 10th Asian Conference on Pharmacoepidemiology, Brisbane, Australia, 29 October 2017 - 31 October 2017
Gisev N, 2017, 'An ecological study of the extent and factors associated with the use of fentanyl across Australia', in An ecological study of the extent and factors associated with the use of fentanyl across Australia, 10th Asian Conference on Pharmacoepidemiology, Brisbane, Australia, presented at 10th Asian Conference on Pharmacoepidemiology, Brisbane, Australia, 29 October 2017 - 31 October 2017
Gisev N, 2016, 'Does Size Really Matter? Using Big Data to Examine the Patterns and Predictors of Opioid Utilisation in Australia', in Does Size Really Matter? Using Big Data to Examine the Patterns and Predictors of Opioid Utilisation in Australia, 2016 Australasian Pharmaceutical Science Association Annual Conference, Sydney, Australia, presented at 2016 Australasian Pharmaceutical Science Association Annual Conference, Sydney, Australia, 02 December 2016 - 05 December 2016
Gisev N, 2015, 'Opioid Substitution Therapy among Prisoners: Longitudinal Findings from a Data Linkage Study', in Opioid Substitution Therapy among Prisoners: Longitudinal Findings from a Data Linkage Study, 2015 Australasian Pharmaceutical Science Association/Australasian Society of Clinical and Experimental Pharmacologist and Toxicologists Scientific Meeting, Hobart, Australia, presented at 2015 Australasian Pharmaceutical Science Association/Australasian Society of Clinical and Experimental Pharmacologist and Toxicologists Scientific Meeting, Hobart, Australia, 29 November 2015 - 02 December 2015
Gisev N, 2015, 'An ecological study of the extent and factors associated with use of prescription and over-the-counter codeine in Australia', in An ecological study of the extent and factors associated with use of prescription and over-the-counter codeine in Australia, 2015 Australasian Pharmaceutical Science Association/Australasian Society of Clinical and Experimental Pharmacologist and Toxicologists Scientific Meeting, presented at 2015 Australasian Pharmaceutical Science Association/Australasian Society of Clinical and Experimental Pharmacologist and Toxicologists Scientific Meeting, 29 November 2015 - 02 December 2015
Gisev N, 2015, 'A cost-effectiveness analysis of opioid substitution therapy upon release from prison', in A cost-effectiveness analysis of opioid substitution therapy upon release from prison, 2015 Australasian Professional Society on Alcohol and Other Drugs Conference, presented at 2015 Australasian Professional Society on Alcohol and Other Drugs Conference, 08 November 2015 - 11 November 2015
Gisev N, 2015, 'Estimating the extent and predictors of pharmaceutical opioid use in Australia in 2013', in Estimating the extent and predictors of pharmaceutical opioid use in Australia in 2013, 31st International Conference on Pharmacoepidemiology & Therapeutic Risk Management, presented at 31st International Conference on Pharmacoepidemiology & Therapeutic Risk Management, 22 August 2015 - 26 August 2015
Gisev N, 2015, 'The effect of treatment and retention with opioid substitution therapy in reducing crime among opioid-dependent people', in The effect of treatment and retention with opioid substitution therapy in reducing crime among opioid-dependent people, 31st International Conference on Pharmacoepidemiology & Therapeutic Risk Management, presented at 31st International Conference on Pharmacoepidemiology & Therapeutic Risk Management, 22 August 2015 - 26 August 2015
Gisev N, 2014, 'Treatment utilisation and retention with opioid substitution therapy: comparison of buprenorphine and methadone users', in Treatment utilisation and retention with opioid substitution therapy: comparison of buprenorphine and methadone users, 2014 Australasian Professional Society on Alcohol and Other Drugs Conference, presented at 2014 Australasian Professional Society on Alcohol and Other Drugs Conference, 09 November 2014 - 12 November 2014
Gisev N, 2014, 'The impact of opioid substitution therapy on mortality post-release from prison: A retrospective data linkage study', in The impact of opioid substitution therapy on mortality post-release from prison: A retrospective data linkage study, 30th International Conference on Pharmacoepidemiology & Therapeutic Risk Management, presented at 30th International Conference on Pharmacoepidemiology & Therapeutic Risk Management, 24 October 2014 - 27 October 2014
Gisev N, 2014, 'Treatment utilisation and retention with opioid substitution therapy between 2001 and 2010: A comparison of buprenorphine and methadone users', in Treatment utilisation and retention with opioid substitution therapy between 2001 and 2010: A comparison of buprenorphine and methadone users, 30th International Conference on Pharmacoepidemiology & Therapeutic Risk Management, presented at 30th International Conference on Pharmacoepidemiology & Therapeutic Risk Management, 24 October 2014 - 27 October 2014
Gisev N, 2014, 'The cost effectiveness of opioid substitution therapy and impact on criminal offending and mortality.', in The cost effectiveness of opioid substitution therapy and impact on criminal offending and mortality., National Drug and Alcohol Research Centre 2014 Annual Symposium, presented at National Drug and Alcohol Research Centre 2014 Annual Symposium, 08 September 2014 - 08 September 2014
Conference Posters
Gisev N, 2017, 'To what extent do data from pharmaceutical claims under-estimate opioid analgesic utilisation in Australia?', in PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, WILEY, Vol. 26, pp. 106 - 106, presented at National Drug and Alcohol Research Centre 2017 Annual Symposium, 03 October 2017 - 04 October 2017, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000437103900171&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a
Gisev N, 2017, 'To what extent do data from pharmaceutical claims under-estimate opioid analgesic utilisation in Australia?', in To what extent do data from pharmaceutical claims under-estimate opioid analgesic utilisation in Australia?, 33rd International Conference on Pharmacoepidemiology & Therapeutic Risk Management, presented at 33rd International Conference on Pharmacoepidemiology & Therapeutic Risk Management, 26 August 2017 - 30 August 2017
Gisev N, 2016, 'Characteristics of a population-based cohort initiating strong prescription opioids in Australia and factors associated with the type of opioid initiated', in Characteristics of a population-based cohort initiating strong prescription opioids in Australia and factors associated with the type of opioid initiated, National Drug and Alcohol Research Centre 2016 Annual Symposium, presented at National Drug and Alcohol Research Centre 2016 Annual Symposium, 12 September 2016 - 12 September 2016
Gisev N, 2016, 'Initiation of strong prescription opioids in Australia: cohort characteristics and factors associated with the type of opioid initiated', in Initiation of strong prescription opioids in Australia: cohort characteristics and factors associated with the type of opioid initiated, 32nd International Conference on Pharmacoepidemiology & Therapeutic Risk Management, presented at 32nd International Conference on Pharmacoepidemiology & Therapeutic Risk Management, 25 August 2016 - 28 August 2016
Gisev N, 2015, 'A cost-effectiveness analysis of opioid substitution therapy upon release in reducing mortality among prisoners with a history of opioid dependence', in A cost-effectiveness analysis of opioid substitution therapy upon release in reducing mortality among prisoners with a history of opioid dependence, National Drug and Alcohol Research Centre 2015 Annual Symposium, presented at National Drug and Alcohol Research Centre 2015 Annual Symposium, 15 September 2015 - 15 September 2015
Gisev N, 2015, 'A cost-effectiveness analysis of opioid substitution therapy upon release in reducing mortality among prisoners with a history of opioid dependence', in A cost-effectiveness analysis of opioid substitution therapy upon release in reducing mortality among prisoners with a history of opioid dependence, 31st International Conference on Pharmacoepidemiology & Therapeutic Risk Management, presented at 31st International Conference on Pharmacoepidemiology & Therapeutic Risk Management, 22 August 2015 - 26 August 2015
Gisev N, 2014, 'Opioid substitution therapy utilisation among opioid-dependent men and women: A population-based comparative study', in Opioid substitution therapy utilisation among opioid-dependent men and women: A population-based comparative study, National Drug and Alcohol Research Centre 2014 Annual Symposium, presented at National Drug and Alcohol Research Centre 2014 Annual Symposium, 08 September 2014 - 08 September 2014
Gisev N, 2013, 'Engagement with the criminal justice system among opioid-dependent people: Comparison between Indigenous and non-Indigenous offenders', in Engagement with the criminal justice system among opioid-dependent people: Comparison between Indigenous and non-Indigenous offenders, National Drug and Alcohol Research Centre 2013 Annual Symposium, presented at National Drug and Alcohol Research Centre 2013 Annual Symposium, 04 September 2013 - 04 September 2013
Gisev N, 2013, 'Opioid substitution therapy in New South Wales 2001-2012: Comparison between buprenorphine and methadone users', in Opioid substitution therapy in New South Wales 2001-2012: Comparison between buprenorphine and methadone users, National Drug and Alcohol Research Centre 2013 Annual Symposium, presented at National Drug and Alcohol Research Centre 2013 Annual Symposium, 04 September 2013 - 04 September 2013
Gisev N; Hartikainen S; Chen TF; Korhonen M; Bell JS, 2012, 'Mortality associated with benzodiazepine use among community-dwelling older people: results from a population-based retrospective cohort study in Finland', in Mortality associated with benzodiazepine use among community-dwelling older people: results from a population-based retrospective cohort study in Finland, National Medicines Symposium 2012, presented at National Medicines Symposium 2012, 24 May 2012 - 25 May 2012
Gisev N; Hartikainen S; Chen TF; Korhonen M; Bell JS, 2012, 'The risk of death associated with antipsychotic use in community-dwelling older adults: do co-morbidities make a difference?', in The risk of death associated with antipsychotic use in community-dwelling older adults: do co-morbidities make a difference?, National Medicines Symposium 2012, presented at National Medicines Symposium 2012, 24 May 2012 - 25 May 2012
Conference Presentations
Schaffer A; Cairns R; Brown J; Gisev N; Buckley N; Pearson S, 2020, 'Changes in sales of over‐the‐counter and prescription medicines after rescheduling of codeine to a prescription‐only medicine in Australia', in Pharmacoepidemiology and Drug Safety, John Wiley and Sons, presented at International Conference on Pharmacoepidemiology and Therapeutic Risk Management
Conference Abstracts
Peacock A; Gisev N; Memedovic S; Larance B; Brown J; Cairns R; Buckley N; Farrell M; Degenhardt L, 2020, 'Opioid use and harms associated with a sustained-release tapentadol formulation: A post-marketing surveillance study', in Drug and Alcohol Dependence, WILEY, Vol. 206, pp. S57 - S57, http://dx.doi.org/10.1016/j.drugalcdep.2019.107697
Reports
Chrzanowska A; Gisev N; Price O; Sutherland R; Memedovic S; Degenhardt L; Farrell M; Peacock A, 2020, Tapentadol use and harms in Australia: Analysis of opioid sales data and sentinel survey data from people who inject drugs, National Drug and Alcohol Research Centre, UNSW Sydney, Sydney, http://dx.doi.org/10.26190/5ef15b883c0ac
Gisev N; Larney S; Kimber J; Burns L; Weatherburn D; Gibson A; Dobbins T; Mattick R; Butler T; Degenhardt L, 2014, Determining the impact of opioid substitution therapy upon mortality and recidivism among prisoners: A 22 year data linkage study, National Drug and Alcohol Research Centre, University of New South Wales, Sydney, 330, https://ndarc.med.unsw.edu.au/resource/determining-impact-opioid-substitution-therapy-upon-mortality-and-recidivism-among
Nielsen S; Degenhardt L; Hoban B; Gisev N, 2014, Comparing opioids: A guide to estimating oral morphine equivalents (OME) in research, National Drug and Alcohol Research Centre, University of New South Wales, Sydney, NDARC Technical Report, 329, https://ndarc.med.unsw.edu.au/resource/comparing-opioids-guide-estimating-oral-morphine-equivalents-ome-research
Theses / Dissertations
Gisev N, 2014, An Evaluation of Psychotropic Medicines Use: Patterns and Outcomes
Preprints
Costa JDO; Bruno C; Baranwal N; Gisev N; Dobbins T; Degenhardt L; Pearson SA, 2020, Variations in Long-Term Opioid Therapy Definitions: A Systematic Review of Observational Studies Using Routinely Collected Data (2000–2019), http://dx.doi.org/10.22541/au.160192979.95446629/v1